Introduction to TB-500 (Thymosin Beta-4)
TB-500 is a synthetic analog of Thymosin Beta-4, a naturally occurring 43-amino acid peptide that has been identified in virtually all tissue types in preclinical research. Thymosin Beta-4 was first isolated from the thymus gland and has since become a significant focus of molecular biology research due to its role in actin regulation and cellular motility studies.
The synthetic fragment TB-500 contains the active region of the full Thymosin Beta-4 molecule, specifically the actin-binding domain, making it a practical research tool for laboratory investigations.
Molecular Profile & Structure
TB-500 is characterized by its central actin-binding motif (LKKTETQ), which is considered the primary active sequence in research models. The full Thymosin Beta-4 molecule has a molecular weight of approximately 4,921 Da, while the TB-500 fragment retains the functional domains most relevant to preclinical studies.
Actin-Binding Properties
In laboratory settings, Thymosin Beta-4 has been demonstrated to be one of the primary actin-sequestering molecules. Research has shown that it plays a role in regulating actin polymerization, which is fundamental to cellular structure, migration, and division in cell culture models.
Research Applications
Cell Migration Studies
Preclinical research has extensively examined TB-500’s effects on cell migration. In-vitro wound healing assays (scratch assays) have demonstrated that TB-500 may promote cell migration across various cell types in laboratory conditions. These findings have made it a standard reference compound in migration studies.
Angiogenesis Research
Studies in laboratory models have investigated TB-500’s potential role in angiogenesis — the formation of new blood vessels from pre-existing vasculature. In-vitro tube formation assays and preclinical models have provided data suggesting pro-angiogenic properties in research settings.
Inflammatory Response Models
Research has explored TB-500’s interactions with inflammatory pathways in cellular models. Laboratory studies have examined its effects on various inflammatory mediators, contributing to our understanding of peptide-mediated modulation of inflammatory processes in vitro.
Cardiac Research Models
A notable area of TB-500 research involves cardiac cell models. Preclinical studies have investigated Thymosin Beta-4’s effects on cardiac progenitor cells and cardiomyocyte viability assays, generating significant interest in the research community.
TB-500 and BPC-157: Combined Research
Many investigators study TB-500 in combination with BPC-157, as their mechanisms of action appear complementary in preclinical models. The Wolverine Blend provides both peptides in a single preparation for streamlined research protocols.
While BPC-157 research has focused on NO pathway modulation and growth factor expression, TB-500 research centers on actin regulation and cell migration — potentially complementary pathways in tissue modeling studies.
Handling & Storage for Research
TB-500 should be stored in its lyophilized form at -20°C until reconstitution. For preparation:
- Reconstitute with bacteriostatic water or sterile saline
- Allow the lyophilized powder to dissolve naturally — avoid vortexing
- Store reconstituted solutions at 2-8°C
- Use within the stability window appropriate for your experimental timeline
Quality Considerations
As with all research peptides, TB-500 purity is critical. Researchers should verify:
- HPLC purity ≥98%
- Correct molecular weight via mass spectrometry
- Batch-specific Certificate of Analysis
- Proper lyophilization and packaging
Current Research Directions
TB-500 continues to be an active area of preclinical research, with ongoing studies expanding our understanding of Thymosin Beta-4’s molecular interactions. The peptide’s role in actin biology, combined with its demonstrated effects in multiple cell culture systems, ensures its continued relevance in molecular biology and peptide research.
Molecular Peptides offers TB-500 in 5mg and 10mg preparations, each with full third-party analytical documentation.